[ad_1]
Amgen inventory remained flat late Thursday after the biotech firm reported adjusted earnings of $4.70 per share on $6.65 billion in third-quarter gross sales.
X
Analysts polled by FactSet anticipated Amgen (AMGN) earnings of $4.44 per share and $6.56 billion in gross sales.
Within the year-ago interval, Amgen earned $4.08 per share and reported $6.71 billion in gross sales.
For the 12 months, the biotech large raised its outlook. Amgen now expects $26 billion to $26.3 billion in gross sales and adjusted earnings of $17.25 to $17.85 per share. Amgen inventory analysts forecasted earnings of $17.52 per share and $26.14 billion in gross sales.
In after-hours trades on right now’s inventory market, Amgen inventory was muted after shedding 1.2% throughout the common session and shutting at 265.88.
Extra to comply with.
Observe Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Zoetis Inventory Yelps As Animal-Well being Large Hacks $200 Million-Plus Off Its Outlook
Moderna Plummets On Slashed Outlook, Taking BioNTech, Novavax With It
Choices Buying and selling: How To Begin Utilizing Choices, How To Handle Threat
Observe Premarket And After-The-Open Motion With IBD Consultants
Finest Development Shares To Purchase And Watch: See Updates To IBD Inventory Lists
[ad_2]
Source link
